| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94feae0d05ee89a03f0e3dc24c2752d4 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2002-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_562f28114d859ef4c8bbb98b9e4a4b80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c548a5994044098e47353fbf5ad4dda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8a4b914eaaf5de3959406e240ad90ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b3896b052be2c119139ed93b9460abe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30769b8905596cbf4ff3f2047b41539a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1813f10518dcef4a13136e92f94578
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df8c32cd1cb7c4c47d4269c4dec6ae93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e0488cb7b38fe88bcd1aa92228e8f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_078e538f484798f4c028b03d847ccea9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95e90c9cc37bdee1fc2a9375fb93da6d |
| publicationDate |
2004-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2004141112-A |
| titleOfInvention |
Method for determining susceptibility to arteriosclerosis in patients with type 2 diabetes |
| abstract |
A method for determining susceptibility to arteriosclerosis in a type 2 diabetic patient is provided. A method for determining susceptibility to arteriosclerosis in a type 2 diabetic patient, comprising the steps of: (a) collecting a biological sample containing genomic DNA from the type 2 diabetic patient; b) determining the type of base at the position corresponding to the 129th base of exon 7 of the α2 integrin (α2 integrin) gene present on the genomic DNA in the biological sample obtained in the step (a); And (c) determining the susceptibility of the type 2 diabetic patient to arteriosclerosis based on the result obtained in step (b). Susceptibility determination method for [Selection diagram] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013151053-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013151053-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008125738-A3 |
| priorityDate |
2002-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |